Heather Wakelee

Clinical Trials

• A Phase 1/2 Study of Aflibercept Administered in Combination with Pemetrexed and Cisplatin in Patients with Advanced Carcinoma Recruiting
• A Study of ASA404 or Placebo in Combination With Docetaxel in Second-Line Treatment for (Stage IIIb/IV) Non-Small Cell Lung Cancer (ATTRACT-2) Recruiting
• A Study of XL184 With or Without Erlotinib in Adults With Non-Small Cell Lung Cancer Recruiting
• AZD0530 in Treating Patients With Relapsed or Refractory Thymoma or Thymic Cancer Recruiting
• An Observational Study of the Ethnic Impact of Patients Undergoing 2nd Line Treatment for Non-Small Cell Lung Cancer Using Pemetrexed Recruiting
• CT-2103/Carboplatin vs Paclitaxel/Carboplatin for NSCLC in Women With Normal Estradiol Recruiting
• Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery Recruiting
• Identification of Circulating Tumor Cells in the Peripheral Blood of Lung Cancer Patients Recruiting
• A Phase 1 Dose Escalation Study of OMP-21M18 in Subjects With Solid Tumors Recruiting
• Clinical and Pathologic Studies of Patients Undergoing Treatment with EGFR Inhibitors Recruiting
• Immunobiology of Cancer Recruiting
• Microarray Analysis of Gene Expression and Identification of Progenitor Cells in Lung Carcinoma Recruiting
• Ph I Dose-Escalation of AEG40826-2HCI for Advanced Solid Tumors Recruiting
• Phase 1 Trial of Oral Ixabepilone Recruiting
• Phase I Vorinostat Concurrent with Stereotactic Radiosurgery (SRS) in Brain Metastases from Non-Small Cell Lung Cancer Recruiting
• Study of XL518 in Adults With Solid Tumors Recruiting
• Three Different Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide Recruiting
• A Study of Enzastaurin and Erlotinib in Patients With Solid Tumors and Lung Cancer No longer recruiting
• Phase II Bevacizumab, Gemcitabine and Carboplatin in Newly Diagnosed Non-Small Cell Lung Cancer (excluding squamous cell) No longer recruiting
• Phase II Docetaxel / Carboplatin / XRT + Surgical Resection in Stage III NSCLC No longer recruiting
• Phase II trial of bevacizumab in combination with pemetrexed as 2nd line therapy in patients with stable brain metastases from non-small cell lung cancer No longer recruiting
• Safety and Efficacy Clinical Study of SNS-595 in Patients With Advanced Small Cell Lung Cancer Completed
• Study of XL647 in Subjects With NSCLC Who Have Progressed After Responding to Treatment With Gefitinib or Erlotinib No longer recruiting
• Sorafenib in Treating Patients With Refractory Non-Small Cell Lung Cancer No longer recruiting
• A Phase I/II Study of Bexarotene in Combination with ZD1839 (IRESSA®) in the Treatment of Non-Small Cell Lung Cancer Completed
• A Phase I/II Study of HKI-272 in Combination With Paclitaxel in Subjects With Advanced Solid Tumors and Breast Cancer No longer recruiting
• Evaluation of Cyberknife Precision Radiation Delivery System for Unresectable Malignant Lung Cancer No longer recruiting
• PR-104 in Treating Patients With Previously Untreated or Relapsed Small Cell Lung Cancer No longer recruiting
• Safety and Tolerability Study of SNS-314 for Advanced Solid Tumors Completed
• Study of XL647 Administered Orally Daily to Patients With Solid Tumors No longer recruiting